Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(4-Fluorophenyl)benzaldehyde is an aromatic chemical compound characterized by the molecular formula C13H9FO. It features a benzene ring with a fluorine-substituted phenyl group attached to it, along with an aldehyde functional group. 3-(4-FLUOROPHENYL)BENZALDEHYDE is known for its versatile reactivity and valuable properties, making it a significant intermediate in the synthesis of a wide range of products.

164334-74-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 164334-74-1 Structure
  • Basic information

    1. Product Name: 3-(4-FLUOROPHENYL)BENZALDEHYDE
    2. Synonyms: 3-(4-FLUOROPHENYL)BENZALDEHYDE;AKOS BAR-0062;TIMTEC-BB SBB010233;4'-Fluorobiphenyl-3-carboxaldehyde;4'-FLUOROBIPHENYL-3-CARBALDEHYDE;4'-FLUORO[1,1'-BIPHENYL]-3-CARBALDEHYDE;4'-FLUORO-[1,1'-BIPHENYL]-3-CARBOXALDEHYDE
    3. CAS NO:164334-74-1
    4. Molecular Formula: C13H9FO
    5. Molecular Weight: 200.21
    6. EINECS: N/A
    7. Product Categories: pharmacetical
    8. Mol File: 164334-74-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 328.8 °C at 760 mmHg
    3. Flash Point: 221.3 °C
    4. Appearance: /
    5. Density: 1.173 g/cm3
    6. Vapor Pressure: 0.000185mmHg at 25°C
    7. Refractive Index: 1.59
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 3-(4-FLUOROPHENYL)BENZALDEHYDE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-(4-FLUOROPHENYL)BENZALDEHYDE(164334-74-1)
    12. EPA Substance Registry System: 3-(4-FLUOROPHENYL)BENZALDEHYDE(164334-74-1)
  • Safety Data

    1. Hazard Codes: Xi,Xn
    2. Statements: 36/37/38-41-22
    3. Safety Statements: 26-36/37/39-39
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 164334-74-1(Hazardous Substances Data)

164334-74-1 Usage

Uses

Used in Pharmaceutical Industry:
3-(4-Fluorophenyl)benzaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(4-Fluorophenyl)benzaldehyde serves as an essential component in the production of certain pesticides and other agrochemicals. Its incorporation can enhance the effectiveness of these products in agricultural settings.
Used in Organic Compounds Synthesis:
3-(4-Fluorophenyl)benzaldehyde is utilized as an intermediate for synthesizing a variety of organic compounds, contributing to the advancement of organic chemistry and the creation of new materials with diverse applications.
Used in Dye Production:
3-(4-FLUOROPHENYL)BENZALDEHYDE is used as a precursor in the production of dyes, where its specific chemical properties contribute to the color and stability of the final dye products.
Used in Perfumery:
3-(4-Fluorophenyl)benzaldehyde is employed in the perfume industry to create unique and complex fragrances, capitalizing on its aromatic nature to enhance scent profiles.
Used in Flavorings Industry:
In the flavorings sector, 3-(4-Fluorophenyl)benzaldehyde is used to develop distinct and appealing taste profiles for food and beverages, leveraging its aromatic properties to enrich the sensory experience.
Overall, 3-(4-Fluorophenyl)benzaldehyde's applications span across multiple industries, including medicine, agriculture, and the chemical industry, due to its diverse reactivity and valuable chemical attributes.

Check Digit Verification of cas no

The CAS Registry Mumber 164334-74-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,4,3,3 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 164334-74:
(8*1)+(7*6)+(6*4)+(5*3)+(4*3)+(3*4)+(2*7)+(1*4)=131
131 % 10 = 1
So 164334-74-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H9FO/c14-13-6-4-11(5-7-13)12-3-1-2-10(8-12)9-15/h1-9H

164334-74-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50450)  4'-Fluorobiphenyl-3-carboxaldehyde, 98%   

  • 164334-74-1

  • 250mg

  • 979.0CNY

  • Detail
  • Alfa Aesar

  • (H50450)  4'-Fluorobiphenyl-3-carboxaldehyde, 98%   

  • 164334-74-1

  • 1g

  • 3520.0CNY

  • Detail

164334-74-1Relevant articles and documents

Microwave-assisted organic acid-base-co-catalyzed tandem Meinwald rearrangement and annulation of styrylepoxides

Shi, Yi,Li, Siqi,Lu, Yang,Zhao, Zizhen,Li, Pingfan,Xu, Jiaxi

supporting information, p. 2131 - 2134 (2020/02/27)

A novel organic acid-base-co-catalyzed conversion of styrylepoxides into [1,1′-biaryl]-3-carbaldehydes was realized under microwave irradiation. Styrylepoxides first underwent an acid-catalyzed Meinwald rearrangement followed by a tandem base-catalyzed Michael addition, aldol addition, and aromatization sequence to generate [1,1′-biaryl]-3-carbaldehydes.

Phenylpropiolic acid small molecular organic compounds and synthetic method and application thereof

-

Paragraph 0074; 0075; 0104; 0105; 0106, (2019/04/13)

The invention relate to a category of novel phenylpropiolic acid small molecular organic compounds as shown in a structural formula (I) or stereisomers, crystals, hydrates or pharmaceutically acceptable salt and an application of the phenylpropiolic acid small molecular organic compounds or stereisomers, crystals, hydrates or pharmaceutically acceptable salt and pharmaceutical compositions comprising the compounds in preparing a GPR40 agonist and drugs for promoting insulin release, treating and/or preventing diabetes or complications, treating diabetes inducing poor therapeutic effect inducedby acquired drug-resistance and complications and the like. The invention also provides a preparation method of the phenylpropiolic acid small molecular organic compounds as shown in the structural formula (I). The phenylpropiolic acid small molecular organic compounds have good anti-diabetes effect and the risk of inducing hypoglycemia is lower than that of conventional drugs.

4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors

Granchi, Carlotta,Rizzolio, Flavio,Bordoni, Vittorio,Caligiuri, Isabella,Manera, Clementina,Macchia, Marco,Minutolo, Filippo,Martinelli, Adriano,Giordano, Antonio,Tuccinardi, Tiziano

, p. 137 - 146 (2016/01/12)

This study reports on a preliminary structure-activity relationship exploration of 4-aryliden-2-methyloxazol-5(4H)-one-based compounds as MAGL/FAAH inhibitors. Our results highlight that this scaffold may serve for the development of selective MAGL inhibi

Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites

Carrasco, Marta P.,Machado, Marta,Gon?alves, Lídia,Sharma, Moni,Gut, Jiri,Lukens, Amanda K.,Wirth, Dyann F.,André, Vania,Duarte, Maria Teresa,Guedes, Rita C.,dos Santos, Daniel J. V. A.,Rosenthal, Philip J.,Mazitschek, Ralph,Prudêncio, Miguel,Moreira, Rui

supporting information, p. 2194 - 2204 (2016/10/19)

The potential of azaaurones as dual-stage antimalarial agents was investigated by assessing the effect of a small library of azaaurones on the inhibition of liver and intraerythrocytic lifecycle stages of the malaria parasite. The whole series was screened against the blood stage of a chloroquine-resistant Plasmodium falciparum strain and the liver stage of P. berghei, yielding compounds with dual-stage activity and sub-micromolar potency against erythrocytic parasites. Studies with genetically modified parasites, using a phenotypic assay based on the P. falciparum Dd2-ScDHODH line, which expresses yeast dihydroorotate dehydrogenase (DHODH), showed that one of the azaaurone derivatives has the potential to inhibit the parasite mitochondrial electron-transport chain. The global urgency in finding new therapies for malaria, especially against the underexplored liver stage, associated with chemical tractability of azaaurones, warrants further development of this chemotype. Overall, these results emphasize the azaaurone chemotype as a promising scaffold for dual-stage antimalarials.

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES

-

Paragraph 000943, (2015/04/15)

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).

Inhibition of prostaglandin E2 production by synthetic minor prenylated chalcones and flavonoids: Synthesis, biological activity, crystal structure, and in silico evaluation

Rullah, Kamal,Mohd Aluwi, Mohd Fadhlizil Fasihi,Yamin, Bohari M.,Abdul Bahari, Mohd Nazri,Wei, Leong Sze,Ahmad, Syahida,Abas, Faridah,Ismail, Nor Hadiani,Jantan, Ibrahim,Wai, Lam Kok

, p. 3826 - 3834 (2014/09/16)

The discovery of potent inhibitors of prostaglandin E2 (PGE 2) synthesis in recent years has been proven to be an important game changer in pharmaceutical industry. It is known that excessive production of PGE2 triggers a

Palladium-catalyzed Suzuki-Miyaura coupling of aryl sulfamates with arylboronic acids

Wang, Zhan-Yong,Ma, Qin-Na,Li, Ren-Hao,Shao, Li-Xiong

, p. 7899 - 7906 (2013/11/19)

Readily available NHC-Pd(ii)-Mp complexes 2 showed efficient catalytic activity toward the Suzuki-Miyaura coupling of aryl sulfamates with arylboronic acids or potassium phenyltrifluoroborate, giving the expected coupling products in good to high yields.

Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition

Zuo, Yinglin,Yu, Yi,Wang, Shuni,Shao, Weiyan,Zhou, Binhua,Lin, Li,Luo, Zhuoyu,Huang, Ruogu,Du, Jun,Bu, Xianzhang

experimental part, p. 393 - 404 (2012/07/27)

A series of biaryl-based chalcones were designed as a combination of the natural chalcone and biphenyl moieties, and synthesized by two step chemistry involving Knoevenagel reaction and microwave assistant Suzuki coupling. Sulforhodamine B (SRB) assay was performed to evaluate the cell viability inhibitory abilities of these compounds against five cancer cell lines (A549, CNE2, SW480, MCF-7, and HepG2) from different tissues. Their Nuclear Factor-κB (NF-κB) nuclear translocation inhibitory activities were further investigated by High Content Analysis (HCA) based assay. Most of the compounds showed moderate to strong anticancer and NF-κB nuclear translocation inhibition activities and potent compounds were found.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 164334-74-1